Blue Horseshoe Stocks: Wednesday’s Runners, Fresh Ideas

Reviewing Yesterday’s Runners

To start off the week yesterday morning we formulated a trio of fresh options idea to track, and we can gladly announce that all three produced the opportunity to net multibag gains. Our options ideas have been as good in 2019 as any time in our eight year history, and we ain to keep that trend going!

Take a look at yesterday’s fresh ideas, and the bullish activity they recorded:

KNDI Weekly $6-7 Calls

$6 Calls – Range: 1.35-2.90 – Max Gain: 115%
$7 Calls – Range: .72-2.10 – Max Gain: 192%
_____

GDXJ Weekly $34-34.50 Calls

$34 Calls – Range: .52-1.02 – Max Gain: 96%
$34.50 Calls – Range: .26-.58 – Max Gain: 123%
_____

GRMN Weekly $74.50-76.50 Calls

$74.50 Calls – Range:
2.90-8.06 – Max Gain: 178%
$75 Calls – Range: 1.52-8.35 – Max Gain: 449%
(There are no $75.50 Calls)
$76 Calls – Range: .71-6.80 – Max Gain: 858%
$76.50 Calls – Range: .72-6.12 – Max Gain: 750%
_____

Fresh Options Ideas – In addition to continuing to keep an eye on the previously mentioned plays, we will also add to the pool with another couple of ideas today. In these cases we are going to go bearish.

Domino’s whiffed on earnings and revenue in its premarket release today, while same-store sales increased only slightly. Meanwhile, the high profile injury to Duke basketball player Zion Williamson last night caused by a Nike shoe malfunction, has the potential to have a deleterious effect on Nike’s stock in the near term.

Domino’s Pizza Inc. DPZ Weekly $270-260 Puts
Nike, Inc. NKE 03/15 $84-83.50 Puts


Extended Watchlist:
ESNC, CVRS, ATNM, HTGM, BOXL, GEVO, KL, GOGO

Blue Horseshoe Stocks: Tech Options Review

OPTIONS REVIEW

We were banking on a market reversal yesterday in tandem with good performances from a couple earnings plays that we formulated some options ideas for, and got everything we wanted.

Both of the plays were in the tech sector, which turned out to see some of the highest incidences of recovery, and it facilitated some very nice gain opportunities for anyone who was paying attention to our ideas.

Despite the appearance of yet another reversal and possibly another down day, we are quite pleased with the double-bag, single-session gains afforded to us by these two tech stocks.

TSLA Weekly $310-317.50 Calls
$275 Calls
– Range: 3.73-8.81 - Max Gain: 136%
$275.50 Calls – Range: 3.10-7.35 – Max Gain: 137%
$276 Calls – Range: 2.41-6.21 - Max Gain: 158%
$276.50 Calls – Range: 2.05-5.04 – Max Gain: 146%
_____

MSFT Weekly $104-107 Calls
$275 Calls
– Range: 2.10-5.40 - Max Gain: 157%
$276 Calls – Range: 2.12-4.45 - Max Gain: 110%
$276 Calls – Range: 1.58-3.58 – Max Gain: 127%
$277 Calls – Range: 1.10-2.75 - Max Gain: 150%

_____

We also had a fresh idea on Wednesday morning with The Boeing Co. BA Weekly $357.50-367.50 Calls and the surge in the markets yesterday also allowed those contracts to get legs and make some very respectable moves:

$275 Calls – Range: 4.00-7.70 - Max Gain: 93%
$275.50 Calls – Range: 2.60-6.00 – Max Gain: 131%
$276 Calls – Range: 1.85-4.32 - Max Gain: 134%
$276.50 Calls – Range: 1.15-2.90 – Max Gain: 152%
$277 Calls – Range: .77-1.85 - Max Gain: 140%
_____

Fresh Ideas:
INTC Weekly $44-45.50 Calls*

*NEVER trade weekly options on a Friday unless you’re an expert level trader with disposable funds!


Extended Watchlist: 
OHGI, NSPR, ATNM, NAUH, GT, PLG, LOGM, TRVN

Blue Horseshoe Stocks: SVSN Review & More

Stereo Vision Entertainment, Inc. SVSN

It was roughly six weeks back that we put SVSN on our radars on a routine news scan, and as we always say, it’s better to be early to the party than late. All the way up until last week, the stock wasn’t trading with any real vigor, but things have picked in a huge way, both in volume and price.

From its low at .08 at the beginning of last week, the stock finished out at a high of .89, for an intraweek rip of 1012% This came on the news that the company will file a $50M Real Estate Investment Trust on behalf of its CannaVision subsidiary, with the goal of organically growing cannabis for the purposes of extracting CBD.


Progressive Care, Inc. RXMD

We also want to swing back around to RXMD this morning, which we intially tagged onthe morning of February 22nd. Since that time the stock has exhibited a fairly steady climb up the chart.

We observed a low of .0663 in RXMD on that first day, and as of Friday’s new high of .129, we had watched as the stock rose 95% over a period of just seven trading sessions. It’s streaking to its highest PPS in nearly five years, so it’s safe to say RXMD is in blue sky breakout territory, and we’ll be eager to continue tracking its movements.



Fate Therapeutics, Inc. FATE

We also wanted to recap the solid move we’ve witnessed in FATE, since mentioning the stock toward the end of January. It dipped slightly to a low of 6.76 shortly thereafter, and has since gone a very impressive run.

The stock reached a new high of 14.02 on Friday, which worked out to a 108% upswing in a matter of less than a month.


Extended Watchlist:
RJDG, ATNM, INPX, NSPR, GNL, OTIV, CLSD, MYSZ

Blue Horseshoe Stocks: RXMD Recap

Nxt-ID, Inc. NXTD

We most recently mentioned NXTD a couple of weeks ago on February 12th, following a long period of consolidation off of the massive run we observed back in December. The stock seemed to be settling down at a bottom, and indeed, it reached its low of 2.00 the very next day.

After a bit of sideways trading NXTD has awakened in a big way on the heels of a key development coming over the newswires (see snippet below). Already in the premarket, it has risen by 100% since our alert, hitting 4.00 in early trading.

In addition to the stock itself, we’re also going to place a couple of contracts in the NXTD options chain in watch, the NXTD 03/16 $2.50 & $5 Calls.

Discover Financial Services and FitPay, Inc., a wholly owned subsidiary of NXT-ID, Inc., today announced a network services agreement to allow devices that are integrated with the FitPay Payment Platform[TM] to provision tokenized payment credentials through Discover® Digital Exchange (DDX). The agreement enables Discover cardholders, along with alliance partner cards, to easily make contactless payment transactions at retail locations with wearable or Internet of Things (IoT) devices that include payment capabilities powered by FitPay[TM] (>>View Full PR)


Progressive Care, Inc. RXMD

We initially flagged RXMD in Thursday’s premarket report after noticing the amount of momentum that had been building up in the stock recently. It managed to finish out the week sustaining that momentum and continuing to head into blue skies, setting a new 52-week high with each uptick.

From Thursday morning’s low of .0663, the stock attained a high of .0979 which workes out to a two day swing of 48% and stand as the highest PPS recorded since 2013.



Fresh Options Idea:
Target Corp. TGT Weekly $75-76.50 Calls


Extended Watchlist:
BPMX, CTRV, GTT, HRG, SPB, IDXG, FINL, ATNM(Bottom-Watch)

Blue Horseshoe Stocks: TEUM Update & More

Pareteum Corp. TEUM

The last time we mentioned TEUM was December 8th, shortly after which time the stock was trading for as little as .661. At the time the company had no involvement in the trendy cryptocurrency space.

Flash forward to this week, and an announcement that the company is adding blockchain capability for cryptocurrency support on its global cloud billing platform has the stock soaring to new highs.

TEUM hit 3.15 yesterday, which marks an increase of 377% in less than three weeks’ time. Volume for the day was on the order of roughly five times the monthly average.

Bitcoin itself has been making a nice rebound after the pullback which followed its big run to nearly $20K, and there is no reason to suspect that the push toward blockchain related technologies, both cryptocurrency and otherwise, is just a passing fad.


INSYS Therapeutics, Inc. INSY - Options Recap

We made our interest in the INSY 01/19 $8 & $9 Calls known yesterday morning, and it barely took any time at all for our ideas to come to fruition.

As we were mentioning yesterday, the company recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy, and the FDA granted Fast Track status to the ‘drug’ for the treatment of a rare genetic disorder (Prader-Willi).

This news allowed for some very nice moves in our designated contracts. The $8 Calls ran from .35-1.00 for a gain of 186%, while the $9′s traded up from .20-.55, trending up 175% on the day.


Ampio Pharmaceuticals, Inc. AMPE

We also want to swing back to remind our readers of last week’s alert on AMPE. We tagged this play seven days ago (four trading days), and saw it trading for as little as 2.57. As of yesterday’s high of 3.55, the stock had thus far risen by 38%

The stock’s peak PPS represented a new annual high, so we’ll be interested to see how the stock performs in blue skies.


Extended Watchlist:
OTIV, FH, NETE, LFIN, GROW, IDXG, WATT, ATNM